Reversal of severe angioproliferative pulmonary arterial hypertension and right ventricular hypertrophy by combined phosphodiesterase-5 and endothelin receptor inhibition

被引：0
|
作者：
Maria A Cavasin
Kimberly M Demos-Davies
Katherine B Schuetze
Weston W Blakeslee
Matthew S Stratton
Rubin M Tuder
Timothy A McKinsey
机构：
[1] University of Colorado Denver,Department of Medicine, Division of Cardiology
[2] University of Colorado Denver,Department of Medicine, Program in Translational Lung Research, Division of Pulmonary Sciences and Critical Care Medicine
来源：
Journal of Translational Medicine | / 12卷
关键词：
Endothelin; Phosphodiesterase; Pulmonary hypertension; Remodeling;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [1] Reversal of severe angioproliferative pulmonary arterial hypertension and right ventricular hypertrophy by combined phosphodiesterase-5 and endothelin receptor inhibition
    Cavasin, Maria A.
    Demos-Davies, Kimberly M.
    Schuetze, Katherine B.
    Blakeslee, Weston W.
    Stratton, Matthew S.
    Tuder, Rubin M.
    McKinsey, Timothy A.
    [J]. JOURNAL OF TRANSLATIONAL MEDICINE, 2014, 12
  • [2] Endothelin receptor blockade combined with phosphodiesterase-5 inhibition increases right ventricular mitochondrial capacity in pulmonary arterial hypertension
    Mouchaers, Koen T. B.
    Schalij, Ingrid
    Versteilen, Amanda M. G.
    Hadi, Awal M.
    Amerongen, Geerten P. van Nieuw
    van Hinsbergh, Victor W. M.
    Postmus, Pieter E.
    van der Laarse, Willem J.
    Vonk-Noordegraaf, Anton
    [J]. AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY, 2009, 297 (01): : H200 - H207
  • [3] Reversal of Right Ventricular Hypertrophy and Dysfunction by Remodulin in a Rat Model of Severe Angioproliferative Pulmonary Arterial Hypertension
    Al Ghouleh, Imad
    Vanderpool, Rebecca
    Baust, Jeffrey
    Shiva, Sruti
    Tofovic, Stevan
    Hu, Jian
    Gladwin, Mark
    Pagano, Patrick
    [J]. CHEST, 2015, 148 (04)
  • [4] Endothelin receptor (ETR) blockade combined with phosphodiesterase-5 (PDE5) inhibition prevents right ventricular hypoxia in Pulmonary Hypertension
    Mouchaers, Koen Thijs Bert
    Wong, Yeun-Ying
    Schalij, Ingrid
    Jaspers, Richard T.
    Amerongen, Geerten P. van Nieuw
    Vonk-Noordegraaf, Anton
    van der Laarse, Willem J.
    [J]. FASEB JOURNAL, 2008, 22
  • [5] Predictors of the response to combined therapy with phosphodiesterase-5 inhibitors and endothelin receptor antagonists in pulmonary arterial hypertension
    Garcia, A. R.
    Blanco, I.
    Lopez Meseguer, M.
    Domingo Morera, J. A.
    Martin Ontiyuelo, C.
    Tura Ceide, O.
    Otero Gonzalez, I.
    Escribano Subias, P.
    Albert Barbera, J.
    [J]. EUROPEAN RESPIRATORY JOURNAL, 2022, 60
  • [6] Oral Therapies for Pulmonary Arterial Hypertension Endothelin Receptor Antagonists and Phosphodiesterase-5 Inhibitors
    Channick, Richard
    Preston, Iona
    Klinger, James R.
    [J]. CLINICS IN CHEST MEDICINE, 2013, 34 (04) : 811 - +
  • [7] Reversal of Right Ventricular Hypertrophy and Dysfunction by Prostacyclin in a Rat Model of Severe Pulmonary Arterial Hypertension
    Vanderpool, Rebecca R.
    Gorelova, Anastasia
    Ma, Yiran
    Alhamaydeh, Mohammad
    Baust, Jeffrey
    Shiva, Sruti
    Tofovic, Stevan P.
    Hu, Jian
    Nouraie, Seyed Mehdi
    Gladwin, Mark T.
    Sharifi-Sanjani, Maryam
    Al Ghouleh, Imad
    [J]. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2022, 23 (10)
  • [8] Phosphodiesterase-5 inhibitors for the treatment of pulmonary arterial hypertension
    Beltran-Gamez, Miguel E.
    Sandoval-Zarate, Julio
    Pulido, Tomas
    [J]. ARCHIVOS DE CARDIOLOGIA DE MEXICO, 2015, 85 (03): : 215 - 224
  • [9] Treatment of pulmonary arterial hypertension with phosphodiesterase-5 inhibitors
    Ghofrani, H. A.
    Grimminger, F.
    [J]. DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 2006, 131 (49) : S311 - S314
  • [10] Role and Effect of Phosphodiesterase-5 Inhibitors and Endothelin Receptor Antagonists in the Treatment of Moderate Pulmonary Hypertension
    Jabuonski, Thiago
    Mazurek, Jeremy A.
    Zolty, Ronald
    [J]. JOURNAL OF CARDIAC FAILURE, 2012, 18 (08) : S64 - S64
12345